1. Home
  2. CCIR vs CYRX Comparison

CCIR vs CYRX Comparison

Compare CCIR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCIR
  • CYRX
  • Stock Information
  • Founded
  • CCIR 2021
  • CYRX 1999
  • Country
  • CCIR United States
  • CYRX United States
  • Employees
  • CCIR N/A
  • CYRX N/A
  • Industry
  • CCIR
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCIR
  • CYRX Health Care
  • Exchange
  • CCIR NYSE
  • CYRX Nasdaq
  • Market Cap
  • CCIR 351.0M
  • CYRX 310.4M
  • IPO Year
  • CCIR 2024
  • CYRX N/A
  • Fundamental
  • Price
  • CCIR $11.35
  • CYRX $5.56
  • Analyst Decision
  • CCIR
  • CYRX Strong Buy
  • Analyst Count
  • CCIR 0
  • CYRX 7
  • Target Price
  • CCIR N/A
  • CYRX $11.29
  • AVG Volume (30 Days)
  • CCIR 271.8K
  • CYRX 500.1K
  • Earning Date
  • CCIR 01-01-0001
  • CYRX 05-06-2025
  • Dividend Yield
  • CCIR N/A
  • CYRX N/A
  • EPS Growth
  • CCIR N/A
  • CYRX N/A
  • EPS
  • CCIR 0.16
  • CYRX N/A
  • Revenue
  • CCIR N/A
  • CYRX $228,385,000.00
  • Revenue This Year
  • CCIR N/A
  • CYRX N/A
  • Revenue Next Year
  • CCIR N/A
  • CYRX $5.30
  • P/E Ratio
  • CCIR $68.59
  • CYRX N/A
  • Revenue Growth
  • CCIR N/A
  • CYRX N/A
  • 52 Week Low
  • CCIR $9.92
  • CYRX $4.58
  • 52 Week High
  • CCIR $12.80
  • CYRX $17.41
  • Technical
  • Relative Strength Index (RSI)
  • CCIR N/A
  • CYRX 46.30
  • Support Level
  • CCIR N/A
  • CYRX $5.21
  • Resistance Level
  • CCIR N/A
  • CYRX $5.97
  • Average True Range (ATR)
  • CCIR 0.00
  • CYRX 0.59
  • MACD
  • CCIR 0.00
  • CYRX 0.03
  • Stochastic Oscillator
  • CCIR 0.00
  • CYRX 54.39

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: